Anti-relaxation therapy in GORD

Gut

Volumn 50, Issue 1, 2002, Pages 6-7

  Tack, J ^a,b   Sifrim, D ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; ATROPINE; BACLOFEN; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; MORPHINE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTON PUMP INHIBITOR;

DRUG EFFICACY; DRUG MECHANISM; GASTROESOPHAGEAL REFLUX; HUMAN; LOWER ESOPHAGUS SPHINCTER; PRIORITY JOURNAL; SHORT SURVEY; SMOOTH MUSCLE RELAXATION; STOMACH ACID SECRETION;

ANTACIDS; BACLOFEN; ESOPHAGOGASTRIC JUNCTION; GABA AGONISTS; GASTROESOPHAGEAL REFLUX; HUMANS; TREATMENT OUTCOME;

EID: 0036135330     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.50.1.6     Document Type: Short Survey

References (18)

1. How well can quantitative 24-hour intraesophageal pH monitoring distinguish various degrees of reflux disease?
2. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis
3. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis
4. Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal reflux
5. Mechanisms of gastroesophageal reflux in ambulant healthy human subjects
6. Motor events underlying gastro-esophageal reflux in ambulant patients with reflux esophagitis
7. Composition of the postprandial refluxate in patients with gastroesophageal reflux disease
8. Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations
9. The esophagogastric junction
10. Medical treatment of gastroesophageal reflux disease - Beyond the proton pump inhibitors
11. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects
12. B agonist baclofen in patients with gastro-oesophageal reflux disease
13. Double blind comparison of omeprazole versus cimetidine in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring
14. Healing and relapse of severe peptic esophagitis after treatment with omeprazole
15. Combined gastric and esophageal 24-hour pH monitoring and esophageal manometry in patients with reflux disease resistant to treatment with omeprazole
16. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole
17. Effect of omeprazole (PPI) on ratio of acid to nonacid gastroesophhageal reflux. Studies using simultaneous intraesophageal impedance and pH measurement
18. Gastro-esophageal reflux disease refractory to proton pump inhibitors: Acid, bile reflux, or both?